Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin C studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants

Goc et al., European Journal of Microbiology and Immunology, doi:10.1556/1886.2021.00022
Jan 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin C for COVID-19
7th treatment shown to reduce risk in September 2020
 
*, now known with p = 0.000000098 from 67 studies, recognized in 10 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
In Vitro study testing combinations of plant extracts and micronutrients with several variants of SARS-CoV-2. A combination of vitamin C, N-acetylcysteine, curcumin, quercetin, resveratrol, theaflavin, naringenin, baicalin, and broccoli extract showed the highest inhibition of RBD binding, and also decreased RdRp, furin, and cathepsin L activity.
12 preclinical studies support the efficacy of vitamin C for COVID-19:
Vitamin C has been identified by the European Food Safety Authority (EFSA) as having sufficient evidence for a causal relationship between intake and optimal immune system function EFSA, Galmés, Galmés (B). Vitamin C plays a key role in the immune system, supporting the production and function of leukocytes, or white blood cells, which defend against infection and disease, including the production of lymphocytes, which make antibodies, and enhancing phagocytosis, the process by which immune system cells ingest and destroy viruses and infected cells. Vitamin C is an antioxidant, protecting cells from damage caused by free radicals. Vitamin C inhibits SARS-CoV-2 3CLpro Malla, Đukić and inhibits SARS-CoV-2 infection by reducing ACE2 levels in a dose-dependent manner Zuo. Intracellular levels of vitamin C decline during COVID-19 hospitalization suggesting ongoing utilization and depletion of vitamin C Boerenkamp. Threonic acid, a metabolite of vitamin C, is lower in mild and severe cases, consistent with increased need for and metabolization of vitamin C with moderate infection, but more limited ability to produce threonic acid in severe infection due to depletion or existing lower levels of vitamin C Albóniga. Symptomatic COVID-19 is associated with a lower frequency of natural killer (NK) cells, and vitamin C has been shown to improve NK cell numbers and functioning Graydon, Vojdani.
Study covers quercetin, curcumin, N-acetylcysteine, and vitamin C.
Goc et al., 21 Jan 2022, peer-reviewed, 5 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperVitamin CAll
Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
Anna Goc, Aleksandra Niedzwiecki, Vadim Ivanov, Svetlana Ivanova, Matthias Rath
doi:10.1556/1886.2021.00022
Despite vaccine availability, the global spread of COVID-19 continues, largely facilitated by emerging SARS-CoV-2 mutations. Our earlier research documented that a specific combination of plant-derived compounds can inhibit SARS-CoV-2 binding to its ACE2 receptor and controlling key cellular mechanisms of viral infectivity. In this study, we evaluated the efficacy of a defined mixture of plant extracts and micronutrients against original SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. The composition containing vitamin C, N-acetylcysteine, resveratrol, theaflavin, curcumin, quercetin, naringenin, baicalin, and broccoli extract demonstrated a highest efficacy by inhibiting the receptor-binding domain (RBD) binding of SARS-CoV-2 to its cellular ACE2 receptor by 90%. In vitro exposure of test pseudo-typed variants to this formula for 1 h before or simultaneously administrated to human pulmonary cells resulted in up to 60% inhibition in their cellular entry. Additionally, this composition significantly inhibited other cellular mechanisms of viral infectivity, including the activity of viral RdRp, furin, and cathepsin L. These findings demonstrate the efficacy of natural compounds against SARS-CoV-2 including its mutated forms through pleiotropic mechanisms. Our results imply that simultaneous inhibition of multiple mechanisms of viral infection of host cells could be an effective strategy to prevent SARS-CoV-2 infection.
References
Andreano, Piccini, Licastro, Casalino, Johnson et al., SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma, Proc Natl Acad Sci, doi:10.1073/pnas.2103154118
Barbour, Rayya, Houssam, El-Hakim, Niedzwiecki et al., Alleviation of histopathologic effects of avian influenza virus by a specific nutrient synergy, Int J Appl Res Vet Med
Chakraborty, Maity, COVID-19 outbreak: migration, effects on society, global environment and prevention, Sci Total Environ, doi:10.1016/j.scitotenv.2020.138882
Collier, Marco, Ferreira, Meng, Datir et al., Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccineelicited antibodies, Nature, doi:10.1038/s41586-021-03412-7
Deryabin, Lvov, Botikov, Ivanov, Kalinovsky et al., Effects of a nutrient mixture on infectious properties of the highly pathogenic strain of avian influenza virus A/H5N1, Biofactors, doi:10.1002/biof.5520330201
Du, He, Zhou, Liu, Zheng et al., The spike protein of SARS-CoV-a target for vaccine and therapeutic development, Nat Rev Microbiol, doi:10.1038/nrmicro2090
Du, Yang, Zhou, Lu, Li et al., MERS-CoV spike protein: a key target for antivirals, Expert Opin Ther Targets, doi:10.1080/14728222.2017.1271415
Dyson, Hill, Moore, Curran-Sebastian, Tildesley et al., Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics, Nat Commun, doi:10.1038/s41467-021-25915-7
Fehr, Perlman, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol Biol, doi:10.1007/978-1-4939-2438-7_1
Follis, York, Nunberg, Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry, Virology, doi:10.1016/j.virol.2006.02.003
Glowacka, Bertram, Müller, Allen, Soilleux et al., Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol
Goc, Ivanov, Ivanova, Chatterjee, Rath et al., Simultaneous inhibition of SARS-CoV-2 infectivity by a specific combination of plant-derived compounds, Eur J Bio Biotech, doi:10.24018/ejbio.2021.2.5.258
Goc, Niedzwiecki, Rath, Polyunsaturated u-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry, Sci Rep, doi:10.1038/s41598-021-84850-1
Goc, Sumera, Rath, Niedzwiecki, Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions, PLOS ONE, doi:10.1371/journal.pone.0253489
Gopinath, Jokinen, Kurkinen, Pentikäinen, Screening of natural products targeting SARS-CoV-2-ACE2 receptor interface -A MixMD based HTVS pipeline, Front Chem, doi:10.3389/fchem.2020.589769
Ivanov, Goc, Ivanova, Niedzwiecki, Rath, Inhibition of ACE2 expression by Ascorbic acid alone and its combination with other natural compounds, Infect Dis Res Trmt (Auckl), doi:10.1177/1178633721994605
Ivanov, Ivanova, Niedzwiecki, Rath, Effective and safe global public health strategy to fight the COVID-19 pandemic: specific micronutrient combination inhibits Coronavirus cell-entry receptor (ACE2) expression, J Cell Med Nat Health
Jariwalla, Gangapurkar, Pandit, Kalinovsky, Niedzwiecki et al., Micronutrient cooperation in suppression of HIV production in chronically and latently infected cells, Mol Med Rep, doi:10.3892/mmr_00000268
Jariwalla, Roomi, Gangapurkar, Kalinovsky, Niedzwiecki et al., Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids, Biofactors, doi:10.1002/biof.5520310101
Johnson, Xie, Kumari, Lokugamage, Muruato et al., Furin cleavage site is key to SARS-CoV-2 pathogenesis, doi:10.1101/2020.08.26.268854%20Preprint
Li, Structure, function, and evolution of coronavirus spike proteins, Annu Rev Virol, doi:10.1146/annurev-virology-110615-042301
Liu, Luo, Libby, Shi, Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients, Pharmacol Ther, doi:10.1016/j.pharmthera.2020.107587
Ming, Qiang, Involvement of spike protein, furin, and ACE2 in SARS-CoV-2-related cardiovascular complications, SN Compr Clin Med, doi:10.1007/s42399-020-00400-2
Muchtaridi, Fauzi, Ikram, Gazzali, Wahab, Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2, Molecules, doi:10.3390/molecules25173980
Simmons, Gosalia, Rennekamp, Reeves, Diamond et al., Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci
Tian, Huang, Fang, Wu, Furin DB: A database of 20-residue furin cleavage site motifs, substrates and their associated drugs, Int J Mol Sci, doi:10.3390/ijms12021060
Yang, Chen, Hamdoun, Coghi, Ng et al., Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding, Phytomedicine, doi:10.1016/j.phymed.2021.153591
Zhang, Cui, Li, Wang, Yu et al., Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization, Commun Biol, doi:10.1038/s42003-021-02728-4
Zhang, Hamdoun, Chen, Yang, Ip et al., Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with biolayer interferometry, Pharmacol Res, doi:10.1016/j.phrs.2021.105820
Zhang, Rao, Li, Zhu, Liu et al., High dose vitamin C infusion for the treatment of critically ill COVID-19, Ann Intensive Care, doi:10.1186/s13613-020-00792-3
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit